The development of hemocompatible surfaces was a starting point for the foundation of Hemoteq and represents a core competency of the company.

Device surfaces in contact with blood represent a critical interface due to their complex interactions with the patient's coagulation system.

Hemocompatible enhancements can reduce the thrombogenicity of foreign surfaces and thereby help avoid potentially life-threatening thrombotic and thromboembolic events. Such surface modifications are applicable to permanent vascular implants, e.g. stents, grafts or pacemaker leads and interventional or diagnostic devices with temporary exposure to blood, like catheters, port systems and guidewires.